Menu
Recruiting NCT06995807

EL-SHIN Therapy for Depressive Symptoms

No phase Interventional Depressive Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: EL-SHIN THERAPY.
Who it may be relevant to
Registry conditions: Depressive Disorder. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Malaysia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Enhancing the Efficacy of Depression and Low Mood Treatment: A Novel Adjunctive Approach

Overview

This is a research aiming to find the effectiveness of an innovative therapy, EL-SHIN THERAPY, in ameliorating depressive symptoms.

Detailed description

This study evaluates the effectiveness of EL-SHIN® Therapy, a novel adjunctive intervention in alleviating depressive symptoms.

There are three components in this therapy:

1. Lavender Therapy 2. GRATEFULNESS® Therapy 3. Fasting with exercise and light therapy

The study includes two phases: a quantitative clinical trial and a qualitative focus group.

Assessments will use DASS-21, MHQoL, and SQS scales with the intervention delivered in English over 3-4 weeks.

Interventions

  • Other EL-SHIN THERAPY
    Participants will be randomly assigned to Group A and Group B. Group A : Attend a talk on Malaysia Tourism + current coping strategies. Group B : EL-SHIN® Therapy + current coping strategies. Duration of therapies: 2 weeks Assessments using (i) DASS-21 (ii) MHQoL (iii) SLEEP QUALITY SCALE (SQS) at baseline, after 1st week \& 2nd weeks for both groups. Assessment will be done on end of 3rd week to see effect when EL-SHIN Therapy Stopped. Group B participants: Attend a workshop on administration

Primary outcome measures

  • DASS-21 Scale [Time frame: 3 to 4 weeks]
  • Mental Health Quality of Life (MHQoL) [Time frame: 3 to 4 weeks]
  • Sleep Quality Scale (SQS) [Time frame: 3 to 4 weeks]

Eligibility criteria

Inclusion criteria

  • Age: Above 18 yrs old
  • DASS-21 scores:

"Moderately Depressed (Score: 14-20)", "Moderately Anxious (Score: 10-14)" \& "Moderately Stressed (Score: 19-25)"

  • Non-Muslim (Due to legal restriction in Malaysia for this religion)
  • English literate
  • Believers in Creationism

Exclusion criteria

  • Muslim (legal restrictions in Malaysia for this religion).
  • Non-English literate (research will be conducted in English only).
  • Individuals with any other medical conditions or on current medication To reduce potential complications or confounding factors).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Malaysia · 1 center
  • Monash University Malaysia — Kuala Lumpur

Identifiers

NCT: NCT06995807 · MonashUMalaysia

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗